The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement

PURPOSE: To provide consensus recommendations on the use of epidermal growth factor receptor tyrosine kinase inhibitors (egfr-tkis) in patients with advanced or meta-static non-small-cell lung cancer (nsclc). METHODS: Using a systematic literature search, phase ii trials, randomized phase iii trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, P.M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F.A., Soulieres, D., Tsao, M.S., Goss, G.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2009
Materias:
Practice Guideline Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644627/
https://www.ncbi.nlm.nih.gov/pubmed/19229369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644627/
https://www.ncbi.nlm.nih.gov/pubmed/19229369

Ejemplares similares